Ethan McBrayer
Family Medicine · Moultrie, GANPI 1821652843
Payments from drug & device makers
Across 201 payments — averaging $23.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$938
- Novo Nordisk$449
- Amgen$448
- AbbVie$410
- Dexcom, Inc.$287
- Pfizer$256
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,812100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 3 | $938 |
| Novo Nordisk | 20 | $449 |
| Amgen | 22 | $448 |
| AbbVie(2 entities) | 19 | $410 |
| Dexcom, Inc. | 20 | $287 |
| Pfizer | 14 | $256 |
| GSK | 14 | $238 |
| Lilly USA, LLC | 15 | $234 |
| Bayer | 8 | $221 |
| Organogenesis Inc. | 2 | $169 |
| AstraZeneca | 9 | $152 |
| Otsuka America Pharmaceutical, Inc. | 7 | $139 |
| Corium, LLC | 5 | $102 |
| Astellas Pharma US Inc | 5 | $102 |
| Boehringer Ingelheim | 4 | $87 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $66 |
| Merck | 4 | $66 |
| Ironshore Pharmaceuticals Inc. | 3 | $57 |
| Xeris Pharmaceuticals, Inc. | 3 | $54 |
| Sanofi Pasteur Inc. | 3 | $49 |
| Exact Sciences | 3 | $44 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Shield Therapeutics Inc | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Ardelyx, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
| Smith+Nephew | 1 | $14 |
| Athena Bioscience, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$938
- PURAPLY WOUND MATRIX$150
- Ozempic$123
- VRAYLAR$123
- EVENITY$123
How this compares
$4,812 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 206 | $217,312 |
| OzempicSemaglutide | 192 | $201,007 |
| FarxigaDapagliflozin Propanediol | 166 | $135,180 |
| JardianceEmpagliflozin | 87 | $85,408 |
| Repatha SureclickEvolocumab | 108 | $66,095 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 92 | $63,034 |
| EliquisApixaban | 79 | $60,189 |
| EntrestoSacubitril/Valsartan | 62 | $41,833 |
| VraylarCariprazine Hcl | 21 | $32,717 |
| TrulicityDulaglutide | 25 | $25,474 |
| XareltoRivaroxaban | 17 | $13,854 |
| LinzessLinaclotide | 13 | $9,061 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $7,884 |
| DapagliflozinDapagliflozin Propanediol | 12 | $6,389 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 51 | $5,279 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $234 | $242,786231 claims |
| Novo NordiskOzempic | $449 | $201,007192 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $152 | $143,064179 claims |
| Boehringer IngelheimJardiance | $87 | $85,40887 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $238 | $68,188105 claims |
| PfizerEliquis | $256 | $60,18979 claims |
| AbbVieVraylar, Linzess | $410 | $41,77834 claims |
| Johnson & JohnsonXarelto | $17 | $13,85417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Moultrie
- Gary SwartzentruberMoultrie$38K
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.